
Gary P. Fischetti
Director · Anika Therapeutics, Inc.
- 2026
- Aug 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary P. Fischetti files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John B. Henneman III - $73K in ANIK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gary P. Fischetti?
Gary P. Fischetti is a corporate insider, tracked as Director of Anika Therapeutics, Inc. (ANIK). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gary P. Fischetti submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Gary P. Fischetti been buying or selling stock?
Recorded transactions: 2 open-market purchases ($41K) and 0 open-market sales across all tracked filings.